Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
patent laws
Pharma
AZ has defended Tagrisso from generics. But for how long?
As copycat drugmakers circle the gates, AstraZeneca has won a reprieve for lung cancer cash cow Tagrisso—for now.
Fraiser Kansteiner
Apr 26, 2022 11:48pm
Biogen lost its bid for a rehearing on a Tecfidera patent case
Mar 17, 2022 10:45am
AbbVie files Trade Commission complaint against Alvotech
Dec 21, 2021 10:19am
Viatris may not have infringed on Symbicort's patents
Dec 13, 2021 3:50pm
Moderna suffered a blow in its patent feud with Arbutus
Dec 1, 2021 12:42pm
Amgen has delayed the entry of another Enbrel biosimilar
Dec 1, 2021 9:25am
